cyclosporine and Conjunctivitis, Allergic

cyclosporine has been researched along with Conjunctivitis, Allergic in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (10.64)	18.2507
2000's	26 (27.66)	29.6817
2010's	40 (42.55)	24.3611
2020's	18 (19.15)	2.80

Authors

Authors	Studies
Beisse, F; Biermann, J; Bosche, F; Eter, N	1
Cavarzeran, F; Leonardi, A; Righetti, G; Salami, E	1
Calder, V; Dahlmann-Noor, AH; Hingorani, M; Muthusamy, K; Roberts, C	1
Alkan, AA; Culha, D; Demir, S; Dogan, CU; Turker, IC; Tuzer, C	1
Amrane, M; Aragona, P; Bremond-Gignac, D; Doan, S; Ismail, D; Leonardi, A; Montero, J; Németh, J	3
Artesani, MC; Buzzonetti, L; Esposito, M; Fiocchi, AG; Valentini, D; Villani, A	1
Brzheskiy, VV	1
Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H	1
Bruschi, G; Cozzi, L; Ghiglioni, DG; Marchisio, P; Osnaghi, S; Viola, F	1
Bruschi, G; Ghiglioni, DG; Landi, M; Marchisio, PG; Osnaghi, S; Pires Marafon, D; Rosazza, C	1
Bonaldo, A; Lazzarini, D; Leonardi, A; Modugno, RL; Scalora, T	1
Sharma, B; Shrestha, S; Subedi, K	1
Gupta, A; Jain, AK; Malhotra, C; Ram, J; Singh, H	1
Barbosa de Sousa, L; Farias, RJM; Gama, MEA; Lobão, NTM; Mendes, R	1
Ahmad, S; Fajardo-Sanchez, J; Kaye, S; Kriman, J; Parekh, M; Sánchez-Tabernero, S; Weston-Davies, W	1
Karaca, U; Özkaya, D; Usta, G	1
Bengarai, W; Berraho, A; Chokrani, H; Tabet Aouel, S	1
Kumari, R; Mohan, N; Saha, BC; Sinha, BP	1
Akpek, EK; Stern, M; Utine, CA	2
Benítez Del Castillo, JM; Borrego-Sanz, L; Díaz Valle, D; López Abad, C; Méndez Fernández, R; Pato Cour, E; Rodríguez Rodríguez, L	1
Fauquert, JL	1
Kosrirukvongs, P; Vichyanond, P	1
Oray, M; Toker, E	1
Chen, LJ; Pang, CP; Rong, SS; Wan, KH; Young, AL	1
Nigar, V; Semsettin, B; Sinan, E	1
Celani, C; Cesoni Marcelli, A; Duse, M; Lollobrigida, V; Mari, E; Nebbioso, M; Occasi, F; Zicari, A; Zicari, AM	1
Leonardi, A; Pacharn, P; Pleyer, U; Vichyanond, P	1
Dimov, V; Wan, XC	1
Celani, C; Duse, M; Grenga, R; Lollobrigida, V; Nebbioso, M; Zicari, AM	1
Agarwal, A; Ram, J	1
Erdinest, N; Solomon, A	1
Bielory, L; Kumar, S; Syed, BA	1
Dogru, M; Fujishima, H; Ibrahim, OM; Kaido, M; Kojima, T; Tsubota, K	1
Lee, JW; Tam, VT; Wong, AL; Wu, MM; Yau, GS; Yuen, CY	1
Duse, M; Nebbioso, M; Occasi, F; Petrarca, L; Salvatori, G; Zicari, AM	1
Barni, S; Calvani, A; Caputo, R; de Libero, C; di Grande, L; di Simone, L; Mori, F; Novembre, E; Pucci, N; Rusconi, F	1
Ulus, ND; Yücel, OE	1
Jabbarvand Behrbouz, M; Mirshahi, R; Nozarian, Z; Soleimani, M; Tabatabaei, SA	1
Gokhale, NS	1
Esposito, S; Fior, G; Ghiglioni, D; Mori, A; Osnaghi, S	1
Cafarotti, A; De Castro, G; Duse, M; Loffredo, L; Lollobrigida, V; Nebbioso, M; Occasi, F; Pecorella, I; Spalice, A; Villa, MP; Zicari, AM	1
Lapid-Gortzak, R; Mourits, MP; Nieuwendaal, CP; Patryn, EK; van der Meulen, IJE; Westland, T	1
Bellini, LP; Brum, GS; Bulla, MC	1
Anzaar, F; Arif, M; Bhat, P; Farooqui, S; Foster, CS; Gallagher, MJ	1
Kumar, S	2
Messmer, EM	1
Ebihara, N; Fujishima, H; Fukushima, A; Kumagai, N; Nakagawa, Y; Nanba, K; Ohashi, Y; Okamoto, S; Shoji, J; Takamura, E; Uchio, E	1
Denoyer, A; Nochez, Y; Pisella, PJ	1
Katsuta, O; Nakamura, M; Oda, T; Shii, D; Shinomiya, K	1
Armenio, L; Bellizzi, M; Brunetti, L; Cardinale, F; Fanelli, P; Miniello, VL; Procoli, U; Rizzo, G; Spadavecchia, L; Tesse, R	1
Katsuta, O; Nakagawa, S; Nakamura, M; Oda, T; Shii, D; Shinomiya, K; Yoshimi, M	1
Nakamura, M; Oda, T; Shii, D	1
Armenio, L; Bellizzi, M; Fanelli, P; Procoli, U; Rizzo, G; Spadavecchia, L; Tesse, R	1
Katsuta, O; Nakagawa, S; Nakamura, M; Oda, T; Shii, D; Yoshimi, M	1
Calder, V; Dart, JK; Guglielmetti, S	1
Ebihara, N	1
Ebihara, N; Fujishima, H; Fukushima, A; Kumagai, N; Miyazaki, D; Nakagawa, Y; Namba, K; Ohashi, Y; Okamoto, S; Shoji, J; Takamura, E; Uchio, E	1
Bonini, S; Deligianni, V; Lambiase, A; Leonardi, A; Sacchetti, M; Sposato, S	1
De Bacquer, D; De Smedt, S; Fonteyne, Y; Gilbert, C; Kestelyn, P; Nkurikiye, J; Tuft, S	1
Akpek, EK; Stern, ME; Tzu, JH; Utine, CA	1
Kari, O; Saari, KM	1
Jirapongsananuruk, O; Kosrirukvongs, P; Labcharoenwongs, P; Saengin, P; Vichyanond, P; Visitsunthorn, N	1
Bernardini, R; Campa, L; Caputo, R; Cianferoni, A; Lombardi, E; Novembre, E; Pucci, N; Vierucci, A	1
Bräuning, J; Heide, PE; Schlote, T; Tomida, I; Zierhut, M	2
Nenciu, A; Stefan, C	1
Akpek, EK; Christen, W; Dart, JK; Dursun, D; Gottsch, JD; O'Brien, TP; Schein, OD; Watson, S; Yoo, S	1
Kosrirukvongs, P; Luengchaichawange, C	1
Akova, YA; Cetinkaya, A; Dursun, D; Pelit, A	1
Bernardini, R; Campa, L; Caputo, R; de Libero, C; Lombardi, E; Massai, C; Novembre, E; Pucci, N; Vierucci, A	1
Allegri, P; Callegarini, L; Marrè, V; Morchio, AA; Murialdo, U; Musso, C; Napoli, G; Tanca, D	1
Constantinou, M; Daniell, M; Taylor, HR; Vu, HT	1
Gürler, B; Kiliç, A	1
Abitbol, O; Chast, F; Doan, S; Gabison, E; Gatinel, D; Hoang-Xuan, T	1
Dulger, E; Ersoz, TR; Ozcan, AA	1
Nicodin, A	1
Geggel, HS	1
Kaan, G; Ozden, O	1
Desmet, V; el-Asrar, AM; Geboes, K; Missotten, L; Tabbara, KF	1
Bo, P; Chan, CC; Li, Q; Luyo, DA; Whitcup, SM	1
Aranzasti, C; Eder, F; Mendicute, J; Ostolaza, JI; Salaberria, M	1
Hannouche, D; Hoang-Xuan, T; Prisant, O; Robin, H	1
Agis, H; Lechner, K; Liehl, E; Scheiner, O; Semper, H; Sperr, M; Sperr, WR; Susani, M; Valent, P; Valenta, R; Willheim, M	1
Buckley, RJ; Calder, VL; Hingorani, M; Lightman, S; Moodaley, L	1
Buckley, RJ; Calder, VL; Hingorani, M; Lightman, S	1
Gupta, V; Sahu, PK	1
DeFranchis, G; Fregona, IA; Leonardi, A; Plebani, M; Secchi, AG; Violato, D	1
Bleik, JH; Tabbara, KF	1

Reviews

19 review(s) available for cyclosporine and Conjunctivitis, Allergic

Article	Year
Topical cyclosporine A 1 mg/ml for atopic keratoconjunctivitis: Five-year case series of 99 children and young people. Acta ophthalmologica, 2023, Volume: 101, Issue:2 Topics: Administration, Topical; Adolescent; Child; Cohort Studies; Conjunctivitis, Allergic; Cyclosporine; Exanthema; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Ophthalmic Solutions; Treatment Outcome	2023
Emergency and critical care medicine, 2022, Volume: 2, Issue:3 Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling	2022
Vernal Keratoconjunctivitis: A Systematic Review. Clinical reviews in allergy & immunology, 2023, Volume: 65, Issue:2 Topics: Conjunctivitis, Allergic; Cyclosporine; Humans; Ophthalmic Solutions; Tacrolimus; Ulcer	2023
Diagnosing and managing allergic conjunctivitis in childhood: The allergist's perspective. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2019, Volume: 30, Issue:4 Topics: Allergists; Anti-Allergic Agents; Child; Conjunctivitis, Allergic; Cyclosporine; Diagnosis, Differential; France; Histamine Antagonists; Hospitals, University; Humans; Immunoglobulin E; Immunosuppression Therapy; Lubricant Eye Drops; Rhinitis, Allergic; Steroids	2019
Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Current allergy and asthma reports, 2013, Volume: 13, Issue:3 Topics: Allergens; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Epithelium, Corneal; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Recurrence; Tacrolimus	2013
Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis. Ophthalmology, 2013, Volume: 120, Issue:11 Topics: Administration, Topical; Conjunctivitis, Allergic; Cyclosporine; Databases, Factual; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Treatment Outcome	2013
Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2014, Volume: 25, Issue:4 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Blindness; Child; Conjunctivitis, Allergic; Corneal Ulcer; Cyclosporine; Dibenzoxepins; Eosinophils; Histamine H1 Antagonists, Non-Sedating; Humans; Immunosuppression Therapy; Olopatadine Hydrochloride; Oxamic Acid	2014
Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis. Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:4 Topics: Administration, Ophthalmic; Calcineurin Inhibitors; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Tacrolimus; Treatment Outcome	2014
Topical immunomodulators in the management of allergic eye diseases. Current opinion in allergy and clinical immunology, 2014, Volume: 14, Issue:5 Topics: Administration, Topical; Adrenal Cortex Hormones; Conjunctivitis, Allergic; Cyclosporine; Eosinophils; Eye; Humans; Immunomodulation; Lymphocyte Activation; Mast Cells; T-Lymphocytes; Tacrolimus; Treatment Outcome	2014
Current options and emerging therapies for anterior ocular inflammatory disease. Current opinion in allergy and clinical immunology, 2014, Volume: 14, Issue:5 Topics: Anti-Infective Agents; Antibodies, Monoclonal; Chemokine CCL11; Clinical Trials as Topic; Conjunctivitis, Allergic; Cyclosporine; Dibenzoxepins; Dry Eye Syndromes; Fluoroquinolones; Histamine H1 Antagonists; Humans; Immunotherapy; Levofloxacin; Moxifloxacin; Olopatadine Hydrochloride; Uveitis, Anterior	2014
An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis. Paediatric drugs, 2016, Volume: 18, Issue:5 Topics: Conjunctivitis, Allergic; Cyclosporine; Humans; Ophthalmic Solutions	2016
Vernal keratoconjunctivitis: a major review. Acta ophthalmologica, 2009, Volume: 87, Issue:2 Topics: Antibodies; Conjunctivitis, Allergic; Cornea; Cyclosporine; Cytokines; Fibroblasts; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Receptors, Chemokine; Th2 Cells	2009
[Therapeutic options in vernal keratoconjunctivitis]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2009, Volume: 106, Issue:6 Topics: Adrenal Cortex Hormones; Conjunctivitis, Allergic; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents	2009
Atopic keratoconjunctivitis and atopic dermatitis. Current opinion in allergy and clinical immunology, 2010, Volume: 10, Issue:5 Topics: Basophils; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Dermatitis, Atopic; Drug Resistance; Eosinophils; Epithelial Cells; Humans; Interleukin-33; Interleukins; Keratoconjunctivitis; Tacrolimus; Thymic Stromal Lymphopoietin	2010
Clinical review: topical ophthalmic use of cyclosporin A. Ocular immunology and inflammation, 2010, Volume: 18, Issue:5 Topics: Acute Disease; Blepharitis; Conjunctival Diseases; Conjunctivitis, Allergic; Corneal Transplantation; Cyclosporine; Dry Eye Syndromes; Emulsions; Eye Diseases; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Rosacea	2010
[Treatment of eye allergies]. Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:3 Topics: Adrenal Cortex Hormones; Conjunctivitis, Allergic; Cromolyn Sodium; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Tacrolimus	2012
[Ocular injuries due to allergic mechanism]. Oftalmologia (Bucharest, Romania : 1990), 2002, Volume: 53, Issue:2 Topics: Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Immunoglobulin E; Immunosuppressive Agents; Ophthalmic Solutions; Piperidines; Prednisone	2002
Drugs for some common eye disorders. Treatment guidelines from the Medical Letter, 2007, Volume: 5, Issue:53 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antioxidants; Carbonic Anhydrase Inhibitors; Cholinergic Agonists; Conjunctivitis, Allergic; Conjunctivitis, Bacterial; Cyclosporine; Diuretics, Osmotic; Dry Eye Syndromes; Eye Diseases; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Degeneration; Ophthalmic Solutions; Patient Compliance; Patient Selection; Photochemotherapy; Prostaglandins; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Zinc	2007
[Allergic conjunctivitis from cellular involvement to medical practice]. Oftalmologia (Bucharest, Romania : 1990), 2007, Volume: 51, Issue:2 Topics: Adrenal Cortex Hormones; Conjunctivitis, Allergic; Cyclosporine; Drug Therapy, Combination; Eosinophils; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Mast Cells; Ophthalmic Solutions; Tacrolimus; Treatment Outcome	2007

Trials

24 trial(s) available for cyclosporine and Conjunctivitis, Allergic

Article	Year
Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials. Eye (London, England), 2023, Volume: 37, Issue:11 Topics: Adolescent; Child; Conjunctivitis, Allergic; Corneal Injuries; Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Emulsions; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Treatment Outcome	2023
Emergency and critical care medicine, 2022, Volume: 2, Issue:3 Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling	2022
Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis. American journal of ophthalmology, 2020, Volume: 212 Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Dexamethasone; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Keratitis; Male; Patient Safety; Treatment Outcome	2020
Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results. Orphanet journal of rare diseases, 2021, 06-11, Volume: 16, Issue:1 Topics: Complement C5; Conjunctivitis, Allergic; Cyclosporine; Humans; Leukotriene B4; Ophthalmic Solutions; Treatment Outcome	2021
Tacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2017, Volume: 9, Issue:18 Topics: Child; Child, Preschool; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Ointments; Ophthalmic Solutions; Prospective Studies; Recurrence; Tacrolimus; Treatment Outcome	2017
A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. Ophthalmology, 2019, Volume: 126, Issue:5 Topics: Adolescent; Child; Child, Preschool; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emulsions; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Quality of Life; Retrospective Studies; Treatment Outcome	2019
Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2015, Volume: 26, Issue:3 Topics: Child; Conjunctivitis, Allergic; Creatinine; Cross-Over Studies; Cyclosporine; Disease Progression; Double-Blind Method; Drug Resistance; Eye; Female; Humans; Male; Ophthalmic Solutions; Quality of Life; Tacrolimus	2015
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Keratoconjunctivitis; Male; Ophthalmic Solutions; Prospective Studies; Severity of Illness Index; Young Adult	2009
Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2010, Volume: 21, Issue:2 Pt 1 Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Italy; Male; Ophthalmic Solutions	2010
[Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients]. Minerva pediatrica, 2010, Volume: 62, Issue:3 Topics: Adolescent; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Pilot Projects; Prognosis	2010
[A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]. Nippon Ganka Gakkai zasshi, 2011, Volume: 115, Issue:6 Topics: Administration, Topical; Adolescent; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Male; Ophthalmic Solutions; Prospective Studies	2011
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study. The Journal of allergy and clinical immunology, 2011, Volume: 128, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Time Factors	2011
Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial. The British journal of ophthalmology, 2012, Volume: 96, Issue:3 Topics: Administration, Topical; Adolescent; Child; Conjunctivitis, Allergic; Cyclosporine; Dexamethasone; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Prospective Studies; Rwanda; Treatment Outcome; Visual Acuity	2012
A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Asian Pacific journal of allergy and immunology, 2012, Volume: 30, Issue:3 Topics: Adolescent; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Ointments; Ophthalmic Solutions; Prospective Studies; Tacrolimus	2012
Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2002, Volume: 89, Issue:3 Topics: Anti-Allergic Agents; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Humans; Male; Ophthalmic Solutions; Treatment Outcome	2002
A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology, 2004, Volume: 111, Issue:3 Topics: Administration, Topical; Adult; Aged; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Drug Resistance; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Safety	2004
Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2004, Volume: 87, Issue:2 Topics: Administration, Topical; Adolescent; Adult; Child; Child, Preschool; Conjunctivitis, Allergic; Cross-Over Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ketorolac Tromethamine; Male; Ophthalmic Solutions; Probability; Prospective Studies; Severity of Illness Index; Treatment Outcome	2004
Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. The British journal of ophthalmology, 2006, Volume: 90, Issue:4 Topics: Adult; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Severity of Illness Index; Treatment Outcome	2006
Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2006, Volume: 41, Issue:6 Topics: Administration, Topical; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Preservatives, Pharmaceutical; Treatment Outcome	2006
Systemic cyclosporine A in severe atopic keratoconjunctivitis. Ophthalmology, 1997, Volume: 104, Issue:8 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Dermatitis, Atopic; Female; Humans; Hypersensitivity; Immunosuppressive Agents; Keratitis; Kidney; Male; Middle Aged; Prednisone; Time Factors; Treatment Outcome	1997
A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology, 1998, Volume: 105, Issue:9 Topics: Administration, Topical; Adult; Conjunctivitis, Allergic; Corn Oil; Cyclosporine; Double-Blind Method; Drug Carriers; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Prospective Studies; Safety; Treatment Outcome	1998
The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Investigative ophthalmology & visual science, 1999, Volume: 40, Issue:2 Topics: Administration, Topical; Adult; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Double-Blind Method; Female; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Receptors, Interleukin-2; T-Lymphocytes	1999
Topical cyclosporin A in the management of vernal keratoconjunctivitis. Eye (London, England), 2001, Volume: 15, Issue:Pt 1 Topics: Adolescent; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Prospective Studies; Treatment Outcome	2001
Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology, 1991, Volume: 98, Issue:11 Topics: Administration, Topical; Adolescent; Adult; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Humans; Intraocular Pressure; Male; Treatment Outcome	1991

Other Studies

52 other study(ies) available for cyclosporine and Conjunctivitis, Allergic

Article	Year
Treating Severe Pediatric Keratoconjunctivitis with Topical Cyclosporine A. Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:11 Topics: Administration, Topical; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Recurrence	2022
Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis. Ocular immunology and inflammation, 2023, Volume: 31, Issue:9 Topics: Conjunctivitis, Allergic; Cyclosporine; Emulsions; Glucocorticoids; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Patient Satisfaction; Quality of Life	2023
Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis. International ophthalmology, 2023, Volume: 43, Issue:7 Topics: Adult; Allergens; Conjunctivitis, Allergic; Cyclosporine; Desensitization, Immunologic; Humans; Hyperemia; Immunotherapy; Quality of Life; Retrospective Studies	2023
Vernal keratoconjunctivitis in Down syndrome: a case report. BMC ophthalmology, 2023, Mar-17, Volume: 23, Issue:1 Topics: Adolescent; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Down Syndrome; Female; Humans; Inflammation	2023
[Modern possibilities of pathogenetically oriented therapy for dry eye syndrome]. Vestnik oftalmologii, 2023, Volume: 139, Issue:2 Topics: Conjunctiva; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Dry Eye Syndromes; Humans; Immunosuppressive Agents; Keratitis; Ophthalmic Solutions; Tears	2023
Cyclosporine ophthalmic emulsion (Verkazia) for vernal keratoconjunctivitis. The Medical letter on drugs and therapeutics, 2023, 05-01, Volume: 65, Issue:1675 Topics: Calcineurin Inhibitors; Conjunctivitis, Allergic; Cyclosporine; Emulsions; Humans; Immunosuppressive Agents; Ophthalmic Solutions	2023
Role of ocular cytology in vernal keratoconjunctivitis. Immunity, inflammation and disease, 2020, Volume: 8, Issue:1 Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Cytological Techniques; Female; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Tacrolimus	2020
Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine. Ocular immunology and inflammation, 2021, Nov-17, Volume: 29, Issue:7-8 Topics: Administration, Ophthalmic; Adolescent; Adult; Child; Child, Preschool; Conjunctivitis, Allergic; Cornea; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Microscopy, Confocal; Ophthalmic Solutions; Prospective Studies; Quality of Life; Surveys and Questionnaires	2021
Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2020, Volume: 12, Issue:23 Topics: Administration, Topical; Child; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Treatment Outcome	2020
Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus. Ocular immunology and inflammation, 2022, Volume: 30, Issue:5 Topics: Administration, Topical; Alanine; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Ointments; Ophthalmic Solutions; Prospective Studies; Quinolones; Tacrolimus; Treatment Outcome	2022
Vernal Keratoconjunctivitis as the Only Clinical Manifestation of HIV Infection. Ocular immunology and inflammation, 2022, Volume: 30, Issue:6 Topics: Adrenal Cortex Hormones; Child; Conjunctivitis, Allergic; Cyclosporine; HIV Infections; Humans; Male; Ophthalmic Solutions	2022
A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis. Iranian journal of allergy, asthma, and immunology, 2021, Aug-07, Volume: 20, Issue:4 Topics: Child; Conjunctivitis, Allergic; Corneal Ulcer; Cyclosporine; Debridement; Disease Susceptibility; Humans; Immunosuppressive Agents; Male	2021
[Giant shield ulcer]. Journal francais d'ophtalmologie, 2017, Volume: 40, Issue:9 Topics: Adrenal Cortex Hormones; Child; Conjunctivitis, Allergic; Corneal Ulcer; Cyclosporine; Humans; Hyaluronic Acid; Male	2017
Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment. Ocular immunology and inflammation, 2019, Volume: 27, Issue:7 Topics: Administration, Topical; Adult; Biomarkers; Biopsy; Chronic Disease; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Female; Follow-Up Studies; HLA-DR Antigens; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Interleukin-33; Keratoconjunctivitis; Male; Middle Aged; Severity of Illness Index; Young Adult	2019
Oral cyclosporine for severe vernal keratoconjunctivitis in children. Journal francais d'ophtalmologie, 2019, Volume: 42, Issue:1 Topics: Administration, Oral; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Prednisolone; Severity of Illness Index	2019
Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy. Cornea, 2013, Volume: 32, Issue:8 Topics: Adolescent; Adult; Analysis of Variance; Case-Control Studies; Child; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukins; Male; Prospective Studies; Tears; Tumor Necrosis Factor-alpha; Young Adult	2013
Comparison of the effects of topical cyclosporine a 0.05%, cyclosporine a 2%, epinastine hydrochloride 0.05%, and prednisolone acetate 1% on allergic inflammation in an experimental allergic conjunctivitis model. Cornea, 2013, Volume: 32, Issue:11 Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Dibenzazepines; Disease Models, Animal; Drug Therapy, Combination; Histamine H1 Antagonists; Imidazoles; Immunosuppressive Agents; Male; Prednisolone; Rats; Rats, Wistar	2013
High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2014, Volume: 25, Issue:1 Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Case-Control Studies; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Follow-Up Studies; HMGB1 Protein; Humans; Male; Ophthalmic Solutions; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Treatment Outcome	2014
Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors. Seminars in ophthalmology, 2015, Volume: 30, Issue:5-6 Topics: Adolescent; Adult; Allergens; Autoimmunity; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Hypersensitivity; Immunoglobulin E; Immunosuppressive Agents; Male; Microscopy, Confocal; Ophthalmic Solutions; Risk Factors; Skin Tests; Visual Acuity	2015
Images in clinical medicine. Giant papillae in vernal keratoconjunctivitis. The New England journal of medicine, 2014, Apr-24, Volume: 370, Issue:17 Topics: Administration, Ophthalmic; Child; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Male	2014
Functional visual acuity assessment of severe atopic keratoconjunctivitis. Cornea, 2014, Volume: 33 Suppl 11 Topics: Adolescent; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Interferometry; Lipids; Male; Ophthalmic Solutions; Tears; Visual Acuity	2014
Retrospective review on the use of topical cyclosporin a 0.05% for paediatric allergic conjunctivitis in Hong Kong Chinese. TheScientificWorldJournal, 2014, Volume: 2014 Topics: Administration, Topical; Adolescent; Asian People; Child; Conjunctivitis, Allergic; Cyclosporine; Female; Hong Kong; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome	2014
Vernal Keratoconjunctivitis and immune-mediated diseases: One unique way to symptom control? Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2015, Volume: 26, Issue:3 Topics: Adolescent; Asthma; Conjunctivitis, Allergic; Cyclosporine; Dermatitis, Atopic; Disease Progression; Humans; Immunoglobulin E; Male; Omalizumab; Th1 Cells; Th2 Cells	2015
Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis. Singapore medical journal, 2016, Volume: 57, Issue:9 Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Child; Cohort Studies; Conjunctivitis, Allergic; Cornea; Cyclosporine; Drug Administration Schedule; Eye; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Young Adult	2016
New Finding in Vernal Keratoconjunctivitis: Splendore-Hoeppli Phenomenon. Cornea, 2016, Volume: 35, Issue:6 Topics: Adult; Betamethasone; Conjunctivitis, Allergic; Cyclosporine; Cytoplasmic Granules; Eosinophilic Granuloma; Female; Glucocorticoids; Humans; Immunosuppressive Agents	2016
Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. Indian journal of ophthalmology, 2016, Volume: 64, Issue:2 Topics: Algorithms; Conjunctivitis, Allergic; Cyclosporine; Drug Combinations; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Severity of Illness Index; Tacrolimus	2016
Vitamin D levels in children affected by vernal keratoconjunctivitis. Current medical research and opinion, 2017, Volume: 33, Issue:2 Topics: Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Male; Ophthalmic Solutions; Vitamin D	2017
Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops. International ophthalmology, 2018, Volume: 38, Issue:1 Topics: Adolescent; Child; Conjunctiva; Conjunctivitis, Allergic; Cornea; Corneal Ulcer; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Retrospective Studies; Time Factors; Visual Acuity	2018
Topical cyclosporin A in severe allergic conjunctivitis. Cornea, 2008, Volume: 27, Issue:5 Topics: Administration, Topical; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions	2008
Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. Cornea, 2008, Volume: 27, Issue:8 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Conjunctivitis, Allergic; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Signal Transduction; T-Lymphocytes; Tacrolimus; Visual Acuity	2008
[0.05% cyclosporine a for treatment of chronic severe ocular surface disease]. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:4 Topics: Administration, Topical; Adult; Chronic Disease; Conjunctivitis, Allergic; Cyclosporine; Dry Eye Syndromes; Female; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Rosacea; Visual Acuity	2009
Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:4 Topics: Administration, Topical; Ambrosia; Animals; Anti-Allergic Agents; Betamethasone; Capillary Permeability; Cell Degranulation; Conjunctivitis, Allergic; Cromolyn Sodium; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Ketotifen; Male; Mast Cells; Mice; Mice, Inbred BALB C; Ophthalmic Solutions; Ovalbumin; Pruritus	2009
Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction. Current eye research, 2009, Volume: 34, Issue:6 Topics: Animals; Betamethasone; Capillary Permeability; Cell Migration Inhibition; Collagen; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Disease Models, Animal; Eosinophils; Fibrosis; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Ophthalmic Solutions; Polymerase Chain Reaction; RNA, Messenger; Th2 Cells	2009
Transfer of a T-helper type 2 clone into conjunctiva induces corneal damage in mice. Cornea, 2010, Volume: 29, Issue:2 Topics: Animals; Betamethasone; Cell Culture Techniques; Clone Cells; Conalbumin; Conjunctiva; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Disease Models, Animal; Eosinophil Peroxidase; Eosinophilia; Female; Glucocorticoids; Immunosuppressive Agents; Interleukin-5; Lymphocyte Activation; Mice; Mice, Inbred AKR; Th2 Cells	2010
Inhibitory effects of cyclosporine a eye drops on symptoms in late phase and delayed-type reactions in allergic conjunctivitis models. Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:8 Topics: Animals; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Disease Models, Animal; Eosinophils; Freund's Adjuvant; Guinea Pigs; Hypersensitivity, Delayed; Immunosuppressive Agents; Instillation, Drug; Leukocyte Count; Leukocytes, Mononuclear; Male; Ophthalmic Solutions; Ovalbumin; Time Factors	2010
[New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops]. Arerugi = [Allergy], 2010, Volume: 59, Issue:11 Topics: Calcineurin Inhibitors; Conjunctivitis, Allergic; Cyclosporine; Humans; Ophthalmic Solutions; Tacrolimus	2010
Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Cornea, 2012, Volume: 31, Issue:6 Topics: Administration, Topical; Adult; Calcineurin Inhibitors; Conjunctivitis, Allergic; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Ophthalmic Solutions; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Visual Acuity; Young Adult	2012
[Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2002, Volume: 99, Issue:10 Topics: Adolescent; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Male; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome	2002
Topical cyclosporine A (2%) eyedrops in the therapy of atopic keratoconjunctivitis and keratoconjunctivitis vernalis. Advances in experimental medicine and biology, 2002, Volume: 506, Issue:Pt B Topics: Adolescent; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Lacrimal Apparatus Diseases; Male; Ophthalmic Solutions; Palliative Care; Pruritus; Visual Acuity	2002
Topical cyclosporine in the management of shield ulcers. Cornea, 2004, Volume: 23, Issue:2 Topics: Administration, Topical; Adolescent; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Ulcer	2004
Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis. Pediatrics, 2005, Volume: 115, Issue:1 Topics: Adolescent; Aging; Case-Control Studies; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclosporine; Eyelashes; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Reference Values	2005
Long-term follow-up of allergic conjunctivitis in children: the out-patients' department experience (allergic conjunctivitis in children: management and care). European annals of allergy and clinical immunology, 2005, Volume: 37, Issue:1 Topics: Administration, Topical; Adrenal Cortex Hormones; Case Management; Conjunctivitis, Allergic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Italy; Leukotriene Antagonists; Ophthalmic Solutions; Outpatient Clinics, Hospital; Treatment Outcome	2005
[Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]. Journal francais d'ophtalmologie, 2007, Volume: 30, Issue:7 Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Child; Conjunctivitis, Allergic; Cyclosporine; Dexamethasone; Female; Humans; Immunosuppressive Agents; Male; Treatment Outcome	2007
Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Cornea, 2007, Volume: 26, Issue:9 Topics: Administration, Topical; Adolescent; Child; Conjunctivitis, Allergic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Surveys and Questionnaires; Treatment Outcome	2007
Combined therapy for vernal shield ulcer. Clinical & experimental optometry, 2008, Volume: 91, Issue:1 Topics: Adult; Conjunctivitis, Allergic; Corneal Ulcer; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Ophthalmic Solutions; Prednisolone	2008
Successful penetrating keratoplasty in a patient with severe atopic keratoconjunctivitis and elevated serum IgE level treated with long-term topical cyclosporin A. Cornea, 1994, Volume: 13, Issue:6 Topics: Anti-Bacterial Agents; Conjunctivitis, Allergic; Cornea; Corneal Ulcer; Cyclosporine; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Hypergammaglobulinemia; Immunoglobulin E; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions	1994
Therapeutic use of topical cyclosporine. Annals of ophthalmology, 1993, Volume: 25, Issue:5 Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Prognosis; Recurrence; Risk Factors	1993
An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. American journal of ophthalmology, 1996, Volume: 121, Issue:2 Topics: Administration, Topical; Adolescent; Antibodies, Monoclonal; Biopsy; Child; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Epithelium; Female; Humans; Immunity, Cellular; Immunoenzyme Techniques; Immunosuppressive Agents; Major Histocompatibility Complex; Male; Ophthalmic Solutions; Plasma Cells; Stromal Cells	1996
Topical cyclosporine inhibits mast cell-mediated conjunctivitis. Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:13 Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Female; Immunosuppressive Agents; Leukocyte Count; Lymphocytes; Macrophages; Mast Cells; Mice; Mice, Inbred C57BL; Neutrophils; Ophthalmic Solutions; p-Methoxy-N-methylphenethylamine; Prednisolone	1996
Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis. Eye (London, England), 1997, Volume: 11 ( Pt 1) Topics: Administration, Topical; Adult; Child; Chronic Disease; Conjunctivitis, Allergic; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Male	1997
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. International archives of allergy and immunology, 1997, Volume: 114, Issue:1 Topics: Adult; Allergens; Asthma; Basophils; Conjunctivitis, Allergic; Cyclosporine; Female; Histamine Release; Humans; Immunization, Passive; Immunoglobulin E; Immunosuppressive Agents; In Vitro Techniques; Male; Middle Aged; Pollen; Rhinitis, Allergic, Seasonal; Tacrolimus	1997
Effects of cyclosporin A on human conjunctival fibroblasts. Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:10 Topics: Apoptosis; Cell Division; Cell Movement; Cells, Cultured; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Humans; Immunosuppressive Agents; Pemphigoid, Bullous; Procollagen	2001